logo
Callum Hedge Honors Family by Racing for Special Cause

Callum Hedge Honors Family by Racing for Special Cause

Fox Sports24-04-2025
INDYCAR
Callum Hedge races for a special cause.
In 2024, New Zealand-born Hedge made the jump to the INDY NXT by Firestone championship after being crowned the champion in both the Porsche Carrera Cup Australia and Formula Regional Americas championships. He brought with him a Muscular Dystrophy Association of New Zealand sticker to place on the nose cone of his HMD Motorsports entry last season.
He switched teams this offseason, but the sticker is featured on his No. 17 ABEL Motorsports entry this year.
For Hedge, the decal is more than a sticker. The little disc on the nose of his car is a foundation that is special for Hedge.
'A couple years ago, we were walking around the zoo with my nephew (Noah),' he said. 'I think he was 3 or 4 at the time, and he was walking really slow, always really puffed. And we're like, 'That's a bit weird.' We sort of thought nothing of it for a year, and then they went into some testing on him because he really wasn't able to even walk to school or walk up the hills at school.
'So, they went and did some testing, found out it was the Duchenne variant, which is one of the rarest forms of the muscular dystrophy in New Zealand. About 70-ish kids had it at the time.'
Muscular dystrophy is a group of genetic disorders that affects the muscles and causes weakness and loss of muscle mass over time. According to reports, an estimated 2,000 people are affected by muscular dystrophy in New Zealand, with approximately 50 new cases diagnosed each year. While there is no cure for the condition, there are a variety of mobility aids that can help affected individuals.
By comparison, 32 of 100,000 people in the United States are affected by muscular dystrophies.
This news came as a bit of a shock to the Hedge family. Further testing then indicated Noah's younger brother, Thomas, also had the Duchenne variant of muscular dystrophy. As an up-and-coming racing talent and a public figure, Hedge knew he had a responsibility to raise awareness.
'Learning what muscular dystrophy was, it's not really showcased very much at all in New Zealand,' he said. 'I don't know how much it is across the U.S., but learning about it, seeing what it does first-hand in a family sense, I just really felt that I was obligated to do something for them, and the easiest and best way I could do it was to represent muscular dystrophy in New Zealand was go out and do some fundraising. Get some eyes on that team, because they get no government funding. So, to go out there do that fundraising is really important to me and for a lot of kids across New Zealand.'
Hedge finished fourth as a rookie in INDY NXT by Firestone points and began the 2025 season with an eighth-place finish in the March 2 season-opener on the streets of St. Petersburg.
He sees the sticker through his visor every time he straps into his car and wants to deliver for his nephews and everyone else battling the condition.
The sticker creates an inner sense of pride for Hedge.
'There's something really important to me and my family as a whole,' he said. 'Sort of comes as a bit of a shock. To see what it does to them first-hand and how much they struggle to get through life, not only my nephews themselves, but my sister, her partner, their younger brother, they all have to watch them grow up in a wheelchair and really struggle to get through life. So, to carry that logo on my car is pretty important.' in this topic
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Should pharmaceutical advertising in SA be better regulated, and why?
Should pharmaceutical advertising in SA be better regulated, and why?

News24

timean hour ago

  • News24

Should pharmaceutical advertising in SA be better regulated, and why?

Anyone who has travelled to the United States will have been struck by the extent to which medicines, both those requiring a prescription and those that can be bought by consumers without a prescription, are advertised on television. The situation in South Africa is quite different. While there are many advertisements for medicines shown on local television stations, only some are specific about the proprietary (brand) name of the medicine and its indications. Other advertisements focus instead on the indication (the reason for using the medicine), but do not identify it by name. Instead, viewers are urged to approach their pharmacies or medical practitioners. At a different time, an advertisement may be flighted which identifies a medicine, its strength, pack size and perhaps price, but provides no information about what the indication for the medicine is. To what extent does this represent meaningful and justified regulatory control over pharmaceutical marketing? Only two countries with effective medicines regulatory systems allow prescription-only medicines to be advertised directly to the consumer, these being the United States and New Zealand. Other countries, including South Africa, restrict the advertising of prescription-only medicines to the health professionals who can prescribe or dispense them. READ | #InsideTheBox with Dr Andy Gray | Who can prescribe medicines in SA? One of the key justifications for this restriction on the ability of the pharmaceutical industry to market their products is that direct-to-consumer advertising may result in more inappropriate prescribing, when prescribers are under pressure from patients demanding medicines they have seen advertised. Short television advertisements are unlikely to be able to convey a balanced account of the potential benefits and harms of medicines, especially those that are new to the market. South African law contains an interesting variant to regulation in this area. General Regulation 42 issued in terms of the Medicines and Related Substances Act, 1965, allows medicines containing substances in schedules 0 and 1 to be advertised to the public, but requires that those containing substances in schedules 2 to 6 to be advertised 'only for the information of pharmacists, medical practitioners, dentists, veterinarians, practitioners and other authorised prescribers' or 'in a publication which is normally or only made available' to such persons. While Schedule 0 medicines can be bought in any retail outlet, Schedule 1 and 2 medicines can only be obtained from a pharmacy but not self-selected from a shelf. The justification for that particular cut-off is difficult to trace in any policy document. An amendment to the regulation was published for comment in February 2023, but the final regulation has yet to be issued by the minister of health. 'Failure to follow through' The fundamental problem, however, lies in a failure to follow through on the legislation previously passed by Parliament. Section 18C of the current version of the Medicines and Related Substances Act, 1965, contains a prescriptive instruction to the minister. 'The minister shall, after consultation with the relevant industries and other stakeholders, make regulations relating to the marketing of medicines, medical devices or IVDs and such regulations shall also provide for codes of practice for relevant industries,' it states. From 2003 to 2017, the section read: 'The minister shall, after consultation with the pharmaceutical industry and other stakeholders, make regulations relating to the marketing of medicines, and such regulations shall also provide for an enforceable code of practice.' The expansion of the remit to include medical devices and in vitro diagnostics (IVDs) was added by Parliament in 2008 but only took effect in 2017. READ | #InsideTheBox with Dr Andy Gray | Are clinical trial participants in South Africa protected? The wording is peremptory – the minister 'shall' – which leaves no room for delay. While the word 'enforceable' has been removed, the very intent of a regulation is that it should be enforced. That no regulations have been forthcoming in more than 20 years is an extraordinary failure of governance. That failure is compounded by another act of omission. Section 18A of the act states: 'No person shall supply any medicine, medical device or IVD according to a bonus system, rebate system or any other incentive scheme.' The law also enables the minister to 'prescribe acceptable and prohibited acts' in this regard, in consultation with the Pricing Committee. No final regulations have been issued since 2017. The Pricing Committee is established to advise the minister on matters relating to the pricing of medicines, such as the annual maximum increase and the dispensing fees charged by pharmacists and licensed dispensing practitioners. It is already an offence, in terms of Section 29 of the act, for any person to make 'any false or misleading statement in connection with any medicine, scheduled substance, medical device or IVD'. Regulation 42 also states: 'No advertisement for a medicine may contain a statement which deviates from, with or goes beyond the evidence submitted in the application for registration of such medicine with regard to its safety, quality or efficacy where such evidence has been accepted by the authority in respect of such medicine and incorporated into the approved information of such medicine'. While these two provisions may prevent false or misleading advertising, they are limited in their scope. In particular, since no complementary medicines are yet registered by the South African Health Products Regulatory Authority (SAHPRA), none have an approved professional information (previously known as a package insert) or a patient information leaflet. Industry self-regulation The pharmaceutical and medical devices industries have not been idle during this period of government inaction. A non-profit, self-regulatory body, the Marketing Code Authority (MCA), has developed a Code of Marketing Practice, drawing on international guidelines. This code provides for sanctions when rules are broken, following adjudication of a complaint. Fines of up to a maximum of R500 000 can be levied for severe or serious offences, which would, for example, pose 'safety implications for patients'. However, as a self-regulatory body, the MCA cannot require membership by any licensed manufacturer. It means that those manufacturers which are not members of the MCA are not bound by the code and cannot be sanctioned. The MCA therefore advocates that compliance with a code should be a condition to get a licence to operate as a manufacturer. The MCA has also responded to draft regulations on perverse incentives. At a time when deliberate disinformation is being disseminated from many quarters, including from government authorities previously considered to be reliable, a weakened regulatory system cannot simply be allowed to stagger along, in defiance of the express instructions of the legislature. Public safety demands an effective regulatory mechanism to proactively examine pharmaceutical marketing, across all media, the ability to take meaningful action where transgressions are identified and an even playing field for all actors. - Gray is a senior lecturer at the University of KwaZulu-Natal and co-director of the WHO Collaborating Centre on Pharmaceutical Policy and Evidence Based Practice. This is the fourth of a new series of #InsideTheBox columns he is writing for Spotlight. Disclosure: Gray is a member of South Africa's National Essential Medicines List Committee and co-chairs its Expert Review Committee.

IndyCar at Laguna Seca live results, updates today, time, schedule, starting lineup
IndyCar at Laguna Seca live results, updates today, time, schedule, starting lineup

Indianapolis Star

timean hour ago

  • Indianapolis Star

IndyCar at Laguna Seca live results, updates today, time, schedule, starting lineup

Championship leader Alex Palou looks to extend his dominance of the 2025 IndyCar Series season in a 95-lap race at WeatherTech Raceway at Laguna Seca. He starts from the pole position as Pato O'Ward, his closest pursuer in the points, starts 2nd in the Java House Grand Prix of Monterey on the 11-turn, 2.238-mile layout. Palou has won seven races in 2025, Kyle Kirkwood three, O'Ward two and Scott Dixon one. Palou is 99 points clear of second-place O'Ward with four races to go. Race winners earn 50 points. Nathan Brown is your best IndyCar follow, and keep up with coverage throughout the season with IndyStar's motorsports newsletter. We will have leaderboard updates, crashes and highlights throughout, so remember to refresh. Here's the starting lineup for today's @IndyCar race at @WeatherTechRcwy ⬇️Among other things, the entire Andretti trio will start on primaries. Both Pato & Palou start on alternates. 'I think it's great': IndyCar's 2 championship contenders to start from front at Laguna Seca 'It's just so random and bizarre': Josef Newgarden tries to make sense of painful IndyCar season McLaren CEO: Zak Brown says IndyCar must remain 'commercially viable' Row 1 1, Alex Palou 2, Pato O'Ward Row 2 3, Colton Herta 4, Josef Newgarden Row 3 5, Will Power 6, David Malukas Row 4 7, Will Power 8, Christian Lundgaard Row 5 9, Graham Rahal 10, Louis Foster Row 6 11, Marcus Armstrong 12, Christian Rasmussen Row 7 13, Scott McLaughlin 14, Kyffin Simpson Row 8 15, Marcus Ericsson 16, Nolan Siegel Row 9 17, Rinus Veekay 18, Kyle Kirkwood Row 10 19, Scott Dixon 20, Santino Ferrucci Row 11 21, Jacob Abel 22, Alexander Rossi Row 12 23, Conor Daly 24, Callum Ilott Row 13 25, Robert Shwartzman 26, Sting Ray Robb Row 14 27, Devlin DeFrancesco Alex Palou swept the pole and race in 2024. Is it going to be one of those weekends? As much as I'd love for the championship fight to get tighter, Palou has exceled here. He didn't run away and hide a year ago, but he was clearly the best car from the jump. This year, Palou has won four of the five natural-terrain road-course races — and in the one he didn't (Mid-Ohio), his small silly mistake cost him the win. We haven't gotten a true Alex Palou beatdown of a weekend since the spring, and it feels like we're due. How will Team Penske fare this weekend? I certainly don't expect a win. I think there's an off-chance we get a podium from either Scott McLaughlin or Will Power. I still think we could get a Penske win before the season ends, but not here. Chip Ganassi Racing has won each of the last three trips to the track, and if I'm making predictions, there's no reason to expect that to change unless something odd happens. The Rookie of the Year race couldn't be tighter. Who has the edge between Louis Foster and Robert Shwartzman? Foster has had a better track record both in qualifying performance and consistency, so in a tie with four races to go, I'll give a slight edge to the Rahal Letterman Lanigan Racing rookie, although I think this very much could be alive until the finale — at an oval, where Prema has gotten the bulk of their strong results this year. (All times ET; all IndyCar sessions are on IndyCar Live, IndyCar Radio and Sirius XM Channel 218) Noon: IndyCar warmup, FS2 3 p.m.: IndyCar race, Fox TV: Coverage begins at 3 p.m. ET, Sunday, July 27, 2025, on Fox. Green flag is scheduled for 3:22 p.m. Will Buxton is the play-by-play voice, with analysts James Hinchcliffe and Townsend Bell. Kevin Lee and Jack Harvey are the pit reporters. Fox Sports app. Watch free with a Fubo trial IndyCar Nation is on SiriusXM Channel 218, IndyCar Live and the IndyCar Radio Network (check affiliates for each race) Sunday: Partly cloudy skies and highs in the 60s.

England in New Zealand 2025
England in New Zealand 2025

Yahoo

time11 hours ago

  • Yahoo

England in New Zealand 2025

October 18 1st Twenty20 international, Christchurch (d/n) (07:15 BST) 20 2nd Twenty20 international, Christchurch (d/n) (07:15 BST) 23 3rd Twenty20 international, Auckland (d/n) (07:15 BST) 26 1st ODI, Mount Maunganui (d/n) (01:00 GMT) 29 2nd ODI, Hamilton (d/n) (01:00 GMT) November 1 3rd ODI, Wellington (Sky Stadium) (d/n) (01:00 GMT) NB Fixtures and start times are subject to change. The BBC is not responsible for any changes that may be made Get cricket news sent straight to your phone

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store